In the study of Hüttenrauch et al., they discovered that Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) is a novel AD-related factor not only in transgenic mice models but also in sporadic AD patients. This evidence concerns the gene GPNMB and Alzheimer disease.